While older retrospective studies showed increased mortality due to cancer in acromegaly, the more recently published reports on acromegaly cohorts with normalized GH and IGF-I levels seem to indicate that the cancer mortality is comparable to the one observed in the general population (117, 119). This evidence concerns the gene GH1 and acromegaly.